锡南酸衍生物:阿尔茨海默氏病的最新发现和发展策略
Yuan Liu1, Zhixian Zhang1, Zeyu Zhu1
1School of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, China.
Mini reviews in medicinal chemistry
|September 2, 2024
概括
新的阿尔茨海默氏症是什么
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特征是粉样β斑块,团,神经炎症和氧化应激.
- 目前的阿尔茨海默病治疗方法通常是单一的目标,并且无法有效地减缓疾病的进展,这凸显了对多个目标治疗策略的需求.
- 基胺酸衍生物,如咖啡酸和酸,具有与AD病理相关的多种药理活性.
研究的目的:
- 审查最近基于咖啡酸和酸的多目标抗阿尔茨海默病 (AD) 衍生物.
- 探索酸衍生物作为潜在的AD治疗方法的新设计策略.
- 为开发有效的多向药物提供见解.
主要方法:
- 关于阿尔茨海默病咖啡酸和酸衍生物的最新研究的文献综述.
- 对药理学活动的分析,包括抗氧化,抗炎和抗粉胺-β沉积特性.
- 讨论结构-活性关系和新药设计的潜力.
主要成果:
- 咖啡酸和酸衍生物显示出针对关键AD病理的显著多目标潜力.
- 这些化合物表现出有前途的神经保护,抗炎,抗氧化和抗胺β聚合活性.
- 该审查确定了设计用于AD治疗的新型肉酸基化合物的有希望的途径.
结论:
- 咖啡酸和酸衍生物代表了阿尔茨海默氏症多目标药物的有希望的类别.
- 对肉酸衍生物的进一步研究为开发更有效的AD疗法提供了战略潜力.
- 这一综述为未来的药物发现工作提供了基础,旨在针对AD的复杂病理.
相关概念视频
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
110
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
110
Dementia
107
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
107


